drugset / Trial / NCT01786629

BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

NCT01786629 ↗

Phase 4 Completed 338 enrolled Braintree Laboratories
RandomizedParallel-groupSingle-blindTreatment

Summary

To compare the safety, tolerance and efficacy of SUPREP Bowel Prep Kit to an FDA approved control as bowel preparations prior to colonoscopy in adult patients.

Timeline

Start
2012-12
Primary completion
2013-05
Completion
—

Outcome

Met primary endpoint

paper OSS resulted in a higher rate of successful (excellent or good) preparation (94.7% vs 85.7%; P = .006) PMID 25028274 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject SUPREP Bowel Prep Kit Unknown — Oral

Indications

No indication recorded.